^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Salivary Gland Cancer |
| Drug: | paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/08/2021
Excerpt:
SYSTEMIC THERAPY FOR SALIVARY GLAND TUMORS: Other Recommend Regimens...Paclitaxel (category 2A for non-adenoid cystic carcinoma [ACC]; category 2B for ACC)
